Third Party Component Operational Aspects of PDL1 Stratification and Biomarkers
Immuno-Oncology 360° Conference Presentation
Presented during the Immuno-Oncology 360° conference, this presentation provides the third-party perspective on operational aspects of immuno-oncology trials, including PDL1 stratification and biomarkers. Q2 Solutions presented as part of a collaborative talk with a panel discussion.
Q2 Solutions has a unique role in immuno-oncology drug development, with clinical laboratory services continually evolving to provide clear results that meet regulatory standards and drive confident decisions for customers.
Download this presentation to learn more.
Patrice Hugo, Ph.D., Chief Scientific Officer
Howard Grossberg, MD, Senior Medical Director, Oncology Center of Excellence, IQVIA
Jeff Hodge, VP, Development Solutions, Oncology Center of Excellence, IQVIA